Back
Aytu BioPharma Quote, Financials, Valuation and Earnings
Sponsored
AYTU
Sponsored
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
37
AYTU
Aytu BioPharma
Last Price:
1.52
Seasonality Move:
12.49%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Aytu BioPharma Price Quote
$1.52
-0.03 (-1.94%)
(Updated: November 16, 2024 at 5:08 AM ET)
Aytu BioPharma Key Stats
Sell
37
Aytu BioPharma (AYTU)
is a Sell
Day range:
$1.50 - $1.76
52-week range:
$1.49 - $3.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.11
P/B ratio:
0.34%
Volume:
63.7K
Avg. volume:
33K
1-year change:
-32.31%
Market cap:
$9.5M
Revenue:
$81M
EPS:
$-2.86
How Much Does Aytu BioPharma Make?
-
How Much Are Aytu BioPharma's Sales Annually?
AYTU Revenues are $81M -
How Much Profit Does Aytu BioPharma's Make A Year?
AYTU net income is -$15.8M
Is Aytu BioPharma Growing As A Company?
-
What Is Aytu BioPharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.42% -
What Is Aytu BioPharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aytu BioPharma Stock Price Performance
-
Did Aytu BioPharma Stock Go Up Last Month?
Aytu BioPharma share price went down by -32.31% last month -
Did AYTU's Share Price Rise Over The Last Year?
AYTU share price fell by -32.31% over the past 1 year
What Is Aytu BioPharma 52-Week High & Low?
-
What Is Aytu BioPharma’s 52-Week High Share Price?
Aytu BioPharma has traded as high as $3.45 over the past 52 weeks -
What Is Aytu BioPharma’s 52-Week Low Share Price?
Aytu BioPharma has traded as low as $1.49 over the past 52 weeks
Aytu BioPharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aytu BioPharma?
-
How Much Debt Does Aytu BioPharma Have?
Total long term debt quarterly is $15.1M -
How Much Cash Does Aytu BioPharma Have?
Cash and short term investments quarterly total is $20M -
What Is Aytu BioPharma’s Book Value Per Share?
Book value per share is 4.64
Is Aytu BioPharma Cash Flow Positive?
-
What Is AYTU Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.4M -
What Is Aytu BioPharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.3M -
What Is Aytu BioPharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$329K
Aytu BioPharma Return On Invested Capital
-
Is Management Doing A Good Job?
AYTU return on invested capital is -32.57% -
What Is Aytu BioPharma Return On Assets?
ROA measures how assets are converting to revenues and is -12.23% -
What Is AYTU Return On Equity?
ROE is a measure of profitability and is -48.64%
Aytu BioPharma Earnings Date & Stock Price
-
What Is Aytu BioPharma's Stock Price Today?
A single share of AYTU can be purchased today for 1.55 -
What Is Aytu BioPharma’s Stock Symbol?
Aytu BioPharma trades on the nasdaq under the ticker symbol: AYTU -
When Is Aytu BioPharma’s Next Earnings Date?
The next quarterly earnings date for Aytu BioPharma is scheduled on February 14, 2025 -
When Is AYTU's next ex-dividend date?
Aytu BioPharma's next ex-dividend date is November 16, 2024 -
How To Buy Aytu BioPharma Stock?
You can buy Aytu BioPharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aytu BioPharma Competitors
-
Who Are Aytu BioPharma's Competitors?
Below is a list of companies who compete with Aytu BioPharma or are related in some way:
Aytu BioPharma Dividend Yield
-
What Is AYTU Dividend Yield?
Aytu BioPharma’s dividend yield currently is 0% -
What Is Aytu BioPharma’s Payout Ratio?
Aytu BioPharma’s payout ratio is 0% -
When Did Aytu BioPharma Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is Aytu BioPharma’s Dividend Per Share?
Aytu BioPharma pays a dividend of $0.00 per share
Aytu BioPharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -41.51% | 20.38% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 8.00 |
Upside from Last Price: | 416.13% |